Table 3.
Five-years observed and net survival of lymphoid neoplasms in Spain.
| Subtypes | N | 5-year observed survival (%) | 95% CI | 5-year net survival (%) | 95% CI |
|---|---|---|---|---|---|
| Lymphoid neoplasm, total | 38,699 | 56.84 | (56.33-57.34) | 62.81 | (62.1-63.52) |
| 1) Hodgkin lymphoma | 3,651 | 80.72 | (79.43-82.04) | 82.6 | (81.25-83.98) |
| 1.1 Classical Hodgkin lymphoma | 3,439 | 80.22 | (78.87-81.58) | 82.13 | (80.72-83.56) |
| 1.2 Hodgkin lymphoma, nodular lymphocyte predominant | 212 | 88.96 | (84.68-93.45) | 90.25 | (85.79-94.93) |
| Non-Hodgkin lymphoma | 35,048 | 54.34 | (53.8-54.88) | 60.74 | (59.97-61.51) |
| 2) Precursor lymphoid neoplasms | 1,464 | 53.8 | (51.27-56.46) | 54.33 | (51.75-57.03) |
| 2.1 B-lymphoblastic leukemia/lymphoma | 474 | 55.15 | (50.78-59.9) | 55.59 | (51.17-60.4) |
| 2.2 T-lymphoblastic leukemia/lymphoma | 235 | 52.71 | (46.59-59.63) | 53.13 | (46.95-60.13) |
| 2.3 Lymphoblastic leukemia/lymphoma | 755 | 53.33 | (49.85-57.06) | 53.92 | (50.36-57.73) |
| 3) Mature B-cell neoplasms | 29,236 | 55.38 | (54.8-55.97) | 62.11 | (61.25-62.99) |
| 3.1 Chronic lymphocytic leukemia/small lymphocytic lymphoma | 6,136 | 62.67 | (61.44-63.93) | 74.54 | (71.86-77.32) |
| 3.2 B-cell prolymphocytic leukemia | 29 | 43.47 | (28.37-66.59) | 47.27 | (29.5-75.74) |
| 3.3 Hairy cell leukemia | 273 | 77.75 | (72.83-83.01) | 85.89 | (79.87-92.37) |
| 3.4 Marginal zone lymphoma | 2,102 | 76.4 | (74.55-78.3) | 83.62 | (81.16-86.15) |
| 3.5 Lymphoplasmacytic lymphoma/Waldenström’s macroglobulinemia | 864 | 60.88 | (57.57-64.38) | 69.8 | (65.45-74.44) |
| 3.6 Plasma cell myeloma/leukemia | 7,324 | 34.71 | (33.59-35.86) | 39.21 | (37.87-40.61) |
| 3.7 Follicular lymphoma | 4,249 | 77.58 | (76.29-78.89) | 83.29 | (81.78-84.83) |
| 3.8 Mantle cell lymphoma | 896 | 46.81 | (43.56-50.3) | 52.42 | (48.64-56.51) |
| 3.9 Diffuse large B-cell lymphoma | 6,930 | 50.48 | (49.29-51.69) | 55.58 | (54.2-57) |
| 3.10 Burkitt lymphoma/leukemia | 417 | 55.92 | (51.33-60.92) | 56.91 | (52.23-62.01) |
| 3.11 Composite Hodgkin and non-Hodgkin lymphoma | 16 | 81.25 | (64.21-100) | 83.35 | (66.09-105.13) |
| 4) Mature-T-cell and NK-cell neoplasms | 2,342 | 58.76 | (56.77-60.83) | 64.19 | (61.78-66.7) |
| 4.1 Mycosis fungoides/Sézary syndrome | 838 | 78.36 | (75.53-81.28) | 85.76 | (82.02-89.66) |
| 4.2 Other peripheral T- cell and NK-cell lymphoma | 1,504 | 47.84 | (45.34-50.48) | 52.12 | (49.18-55.22) |
| 5) Lymphoid neoplasms, NOS | 2,006 | 34.3 | (32.25-36.47) | 41.07 | (38.43-43.9) |
Bold values highlight the main subtypes and its data.